Connective Tissue Growth Factor Human Recombinant (182-250 a.a.) 요약정보 및 구매

4µg

상품 선택옵션 0 개, 추가옵션 0 개

제조사 Prospec
납기일 2-3 주
판매가격 150,000원
포인트 7,500점(구매금액 : 5%)
배송비결제 3,500원   (주문금액 10만원 이상일시 배송비 무료)

선택된 옵션

  • Connective Tissue Growth Factor Human Recombinant (182-250 a.a.) (+0원)

상품 정보

상품 기본설명

4µg

상품 상세설명

Connective Tissue Growth Factor belongs to the CCN family of proteins. The CCN family presently consists of six members in human also known as: Cyr61 (Cystein rich 61), CTGF (Connective Tissue Growth Factor), Nov (Nephroblastoma Overexpressed gene), WISP-1, 2 and 3 (Wnt-1 Induced Secreted Proteins). The CCN genes encode secreted proteins associated with the Extracellular Matrix (ECM) and cell membrane. CCN proteins are matricellular proteins which are involved in the regulation of various cellular functions including: proliferation, differentiation, survival, adhesion and migration. They are expressed in derivatives of the three embryonic sheets and are implicated in the development of kidney, nervous system, muscle, bone marrow, cartilage and bone. During adulthood, they are implicated in wound healing, bone fracture repair, and pathologies such as: fibrosis, vascular ailments and tumorigenesis.

Full length secreted CCN proteins can show an antiproliferative activity, whereas truncated isoforms are likely to stimulate proliferation and behave as oncogenes. The full length protein consists of four modulesModule I shares partial identity with the N-terminal part of the Insulin-like Growth Factor Binding Proteins (IGFBPs).
Module II includes a stretch of 70amino acid residues – which shares sequence identity with the Von Willebrand Factor Type C repeat (VWC).
Module III contains sequences sharing identity with the Thrombospondin type 1 repeat (TSP1) (WSXCSXXCG), which is thought to be implicated in the binding of sulfated glycoconjugates and to be important for cell adhesion. Module IV, also designated CT, is encoded by exon5. It is the leasts conserved one of the four domains at the level of nucleotide sequence, but it appears to be critical for several of the biological functions attributed to the CCN proteins. Module IV resembles the CT domain of several extracellular protein including, Von Willebrand's factor and mucins. Sequence similarities to heparin-binding motifs are also found within this domain. Proteolysis of the secreted full-length CCN proteins that has been reported in the case of CCN2 and CCN3 might result in the production of CCN-derived peptides with high affinity for ligands that full-length CNN proteins bind only poorly. Amino-truncated CCN2 isoforms were biologically active whereas no specific biological activity has been attributed to the truncated CCN3. Although the molecular processes underlying the production of these secreted isoforms is presently unknown, it is important to note that proteolysis occur at the same amino acid residues in both CCN2 and CCN3. An elevated expression of CCN2 has also been detected by Northern blotting in human invasive mammary ductal carcinomas, dermatofibromas, pyogenic granuloma, endothelial cells of angiolipomas and angioleiomyomas, and in pancreatic tumors. A study performed with chondrosarcomas representative of various histological grades established that CCN2 expression was closely correlated with increasing levels of malignancy. In agreement with CCN2 playing a role in brain tumor angiogenesis, immunocytochemistry studies indicated that both glioblastoma tumor cells and proliferating endothelial cells stained positive for CCN2. In astrocytomas, CCN2 expression was particularly elevated in high grade tumors, with a marked effect of CCN2 on cell proliferation. Downregulation of CCN2 expression in these cells was associated with a growth arrest at the G1/S transition while over-expression of CCN2 induced a two-fold increase of the number of cells in the G1 phase. Gene profiling analysis allowed to identify a set of about 50 genes whose expression might account for the proliferative activity of CCN2 in these cells.

CCN2 was seen in a higher proportion of mononuclear cells of patients with acute lymphoblastic leukemia. 

 

많은 제품을 올릴 수 없어서 대표적인 제품만 올립니다.

다른 제품은 Prospec 홈페이지 (www.prospecbio.com)에서 검색하시고, 팩스나 메일로 문의해 주시면 제품 정보를 안내해 드리겠습니다.

많은 관심 부탁드리겠습니다. 

상품문의

등록된 상품문의

상품문의가 없습니다.

반품/교환정보

셀젠바이오샵에서는 다음과 같은 기간 및 내용으로 상품에 대하여 교환, 반품, 환불을 보장하고 있으며, 상품의 반환에 의한

추가비용을 고객에게 부담시지키 않습니다. (, 고객 변심 또는 주문 반복으로 인한 경우의 반환비용은 고객님이 부담하셔야

합니다.)

 

::: 교환 및 반품이 가능한 경우:::

-상품을 공급 받으신 날로부터 7일 이내

  , 상품을 개봉하여 상품가치가 상실된 경우에는 교환/반품이 불가능합니다.

-공급받으신 상품 및 용역의 내용이 표시, 광고 내용과 다르거나 다르게 이행된 경우
-

:::교환 및 반품이 불가능한 경우:::

-하자가 없는 상품을 택배사로부터 인도 받으신 날로부터 20일 이후.
- 고객님의 책임 있는 사유로 상품등이 멸실 또는 훼손된 경우.
- 포장을 개봉하였거나 포장이 훼손되어 상품가치가 현저히 감소한 경우
- 시간의 경과에 의하여 재판매가 곤란할 정도로 상품등의 가치가 현저히 감소한 경우
- 주문 당시 해외 발주 상품의 경우
-

주문 취소 및 반품으로 환불을 요청하실 경우에는 E-mail(celgen-bio@celgen-bio.com)이나 고객만족센터 (042-824-9026)

통해 요청하시면 친절하게 처리해 드리겠습니다.

주문 취소 후 반품 가능 여부를 확인한 다음 3일 이내에 결제 금액을 환불해 드리겠습니다.
  • ㈜셀젠바이오테크, 대표자명: 김성빈, 사업자등록번호: 344-08-00018, 통신판매업종 제 2017-대전유성-0220 호
  • 대전광역시 대덕구 대화로69, 3층(대화동)
  • 대표전화: 042-824-9026 팩스: 042-824-9027
  • E-Mail: celgen-bio@celgen-bio.com
  • Copyright © 2015 Celgen-Bio.tech All rights reserved.